The first new PDA/Innerspace training course is called Fundamentals of Aseptic Processing, which will be held in Carlsbad, Calif., in July.
BETHESDA, Md., June 19, 2023 /PRNewswire-PRWeb/ -- The Parenteral Drug Association (PDA) and Innerspace have announced a long-term strategic partnership to develop PDA training courses that incorporate the use of VR Simulators designed with frame-by-frame risk profiling capabilities. This partnership aims to create a series of hybrid lecture/VR data-driven, immersive, and effective training courses for professionals in the pharmaceutical and biopharmaceutical industries.
The first new PDA/Innerspace training course is called Fundamentals of Aseptic Processing, which will be held in Carlsbad, Calif., in July.
"We are thrilled to partner with Innerspace to provide our members and the industry with innovative and effective training solutions that brings the VR cleanroom into any location," said PDA President and CEO Glenn Wright. "I really like the built in frame-by-frame risk profiling capabilities that can provide trainees with immediate feedback on errors made. When combined with PDA course content, it allows us to offer a new way to reach the industry. We believe this partnership will greatly benefit our industry and our shared goal of delivering world class trainings in locations where a traditional cleanroom environment is not available."
All PDA training courses are designed to meet the pharmaceutical industry's specific training needs and the health authorities' expectations.
"We plan to gradually connect PDA training material with information from Innerspace's frame-by-frame risk profiling, which is a new technology used to create extensive data libraries about risks related to specific processes." Innerspace's Managing Director and Chief Methodologist Sebastian Scheler said. "This approach will help us offer participants a deeper understanding of the risks involved in aseptic processing and help them apply this knowledge to their manufacturing facilities as needed."
"Through the integration of expert insights, regulatory requirements, VR technology and risk profiling data into our course content, we aim to establish a data-driven approach to training by leveraging these resources," said PDA VP of Education David Talmage. "We are excited to initiate this partnership with Innerspace to deliver cutting-edge training courses for the pharmaceutical industry."
For more information, please visit http://www.pda.org/training
About PDA: The Parenteral Drug Association (PDA) is the leading global provider of science, technology, and regulatory information. The PDA creates awareness and understanding of important issues facing the pharmaceutical and biopharmaceutical community and delivers high-quality, relevant education to the industry. Since its founding in 1946 as a nonprofit organization, PDA has been committed to developing scientifically sound, practical technical information and expertise to advance pharmaceutical / biopharmaceutical manufacturing science and regulation, so members can better serve patients. Go to http://www.pda.org/footer/about-pda to learn more.
About Innerspace: Innerspace was founded to empower companies and their employees to sustainably master essential industrial processes. We unite Virtual Reality (VR) technology, training know-how and industry expertise to prevent human errors. We deliver impactful and scalable Virtual Reality Simulators that improve the work performance of cleanroom personnel in pharmaceutical companies worldwide.
Media Contact
Walter Morris, www.pda.org, 1 3016565900, [email protected]
SOURCE PDA
Share this article